Pedro Chaná

1.6k total citations
21 papers, 626 citations indexed

About

Pedro Chaná is a scholar working on Neurology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Pedro Chaná has authored 21 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Pedro Chaná's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Botulinum Toxin and Related Neurological Disorders (9 papers) and Neurological disorders and treatments (9 papers). Pedro Chaná is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Botulinum Toxin and Related Neurological Disorders (9 papers) and Neurological disorders and treatments (9 papers). Pedro Chaná collaborates with scholars based in Chile, Spain and Germany. Pedro Chaná's co-authors include G. Lera, M. Rodriguez, María Rodríguez‐Oroz, Marcelo Merello, Mayela Rodríguez‐Violante, Juan Carlos Martínez‐Castrillo, Tomoko Arakaki, К. Ray Chaudhuri, Nélida Garretto and Diego Ballesteros and has published in prestigious journals such as PLoS ONE, Movement Disorders and Journal of Neural Transmission.

In The Last Decade

Pedro Chaná

20 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Chaná Chile 11 448 123 103 99 92 21 626
Tomoko Arakaki Argentina 13 583 1.3× 167 1.4× 109 1.1× 72 0.7× 72 0.8× 27 760
Chiara Logi Italy 14 424 0.9× 145 1.2× 93 0.9× 83 0.8× 93 1.0× 19 636
Abdul Qayyum Rana Canada 15 629 1.4× 80 0.7× 99 1.0× 89 0.9× 124 1.3× 68 800
Michelle Fullard United States 14 517 1.2× 106 0.9× 110 1.1× 93 0.9× 105 1.1× 30 864
Cristina Pagni Italy 12 324 0.7× 177 1.4× 130 1.3× 51 0.5× 82 0.9× 27 507
Mario Álvarez Cuba 12 706 1.6× 190 1.5× 215 2.1× 94 0.9× 145 1.6× 23 974
Johanne Somme Spain 17 560 1.3× 207 1.7× 188 1.8× 202 2.0× 123 1.3× 27 856
Ming‐Ching Wen Singapore 18 504 1.1× 136 1.1× 240 2.3× 65 0.7× 83 0.9× 26 740
Ece Bayram United States 15 365 0.8× 233 1.9× 176 1.7× 195 2.0× 75 0.8× 62 718
Abbas Dehghani Firouzabadi Iran 6 653 1.5× 124 1.0× 132 1.3× 58 0.6× 135 1.5× 12 808

Countries citing papers authored by Pedro Chaná

Since Specialization
Citations

This map shows the geographic impact of Pedro Chaná's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Chaná with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Chaná more than expected).

Fields of papers citing papers by Pedro Chaná

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Chaná. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Chaná. The network helps show where Pedro Chaná may publish in the future.

Co-authorship network of co-authors of Pedro Chaná

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Chaná. A scholar is included among the top collaborators of Pedro Chaná based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Chaná. Pedro Chaná is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Blázquez, Carmen, Mario Álvarez, Tomoko Arakaki, et al.. (2016). Self‐Assessment of Disability in Parkinson's Disease: The MDS‐UPDRS Part II Versus Clinician‐Based Ratings. Movement Disorders Clinical Practice. 4(4). 529–535. 13 indexed citations
2.
Dressler, Dirk, Roongroj Bhidayasiri, Saeed Bohlega, et al.. (2015). Strategies for treatment of dystonia. Journal of Neural Transmission. 123(3). 251–258. 23 indexed citations
3.
Juri, Carlos, Pedro Chaná, Vasko Kramer, et al.. (2015). Imaging Nigrostriatal Dopaminergic Deficit in Holmes Tremor with 18F-PR04.MZ-PET/CT. Clinical Nuclear Medicine. 40(9). 740–741. 9 indexed citations
4.
Nicholas, Anthony P., Rupam Borgohain, Pedro Chaná, et al.. (2014). A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease. Journal of Parkinson s Disease. 4(3). 361–373. 36 indexed citations
5.
Martínez‐Martín, Pablo, Carmen Rodríguez‐Blázquez, Mario Álvarez, et al.. (2014). Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale. Parkinsonism & Related Disorders. 21(1). 50–54. 236 indexed citations
6.
Chaná, Pedro, et al.. (2014). Effectiveness of exercise to reduce falls and injuries in elderly people. Annals of Physical and Rehabilitation Medicine. 57. e152–e152. 1 indexed citations
7.
Hutchinson, Michael, Ulrich Raff, Pedro Chaná, & Isidro Huete. (2014). Spin-Lattice Distribution MRI Maps Nigral Pathology in Progressive Supranuclear Palsy (PSP) during Life: A Pilot Study. PLoS ONE. 9(1). e85194–e85194. 3 indexed citations
8.
Chaná, Pedro, et al.. (2014). Manejo de la sialorrea en personas con enfermedad de Parkinson mediante terapia conductivo conductual y estimulación termo-táctil. Revista chilena de neuro-psiquiatría. 52(3). 160–166. 2 indexed citations
9.
Chaná, Pedro, et al.. (2012). Olfactory Deficits and Cognitive Dysfunction in Parkinson’s Disease. Neurodegenerative Diseases. 10(1-4). 179–182. 29 indexed citations
10.
Chaná, Pedro. (2009). Avances en tratamiento medico de la enfermedad de Parkinson [Advances in the medical treatment of Parkinson's disease]. Parkinsonism & Related Disorders. 15. S22–S25. 1 indexed citations
11.
Chaná, Pedro. (2009). O.024 Advances in the medical treatment of Parkinson's disease. Parkinsonism & Related Disorders. 15. S7–S7. 1 indexed citations
12.
Chaná, Pedro, et al.. (2008). Tratamiento del Blefaroespasmo y Síndrome de Meige con toxina botulínica. Experiencia y seguimiento en 18 casos.. Revista Ecuatoriana de Neurologia. 17. 8–12.
13.
Juri, Carlos, Paola Viviani, & Pedro Chaná. (2008). Features associated with the development of non-motor manifestations in Parkinson's disease. Arquivos de Neuro-Psiquiatria. 66(1). 22–25. 11 indexed citations
14.
Juri, Carlos, et al.. (2005). Quetiapine for Insomnia in Parkinson Disease. Clinical Neuropharmacology. 28(4). 185–187. 58 indexed citations
15.
Chaná, Pedro, et al.. (2003). Perspectivas de la terapia con toxina botulínica en distonia: a view. Revista chilena de neuro-psiquiatría. 41(2). 1 indexed citations
16.
Chaná, Pedro, et al.. (2003). Botulinum toxin type A inprophylactic treatment of migraine headaches: a preliminarystudy. The Journal of Headache and Pain. 4(3). 146–151. 55 indexed citations
17.
Dressler, Dirk & Pedro Chaná. (2002). La toxina botulínica tipo B: dónde estamos. Revista chilena de neuro-psiquiatría. 40(1). 1 indexed citations
18.
Chaná, Pedro, et al.. (1998). [Accessibility to the specific pharmacotherapy for Parkinson disease, in Santiago de Chile].. PubMed. 126(11). 1355–61. 5 indexed citations
19.
Chaná, Pedro, et al.. (1997). Gabapentin and motor fluctuations in parkinson's disease. Movement Disorders. 12(4). 608–608. 16 indexed citations
20.
Wolff, C, et al.. (1992). [The hepatic porphyrias: experience with 105 cases].. PubMed. 120(3). 259–66. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Arakaki Breakdown of academic impact, for papers by Chiara Logi Breakdown of academic impact, for papers by Abdul Qayyum Rana Breakdown of academic impact, for papers by Michelle Fullard Breakdown of academic impact, for papers by Cristina Pagni Breakdown of academic impact, for papers by Mario Álvarez Breakdown of academic impact, for papers by Johanne Somme Breakdown of academic impact, for papers by Ming‐Ching Wen Breakdown of academic impact, for papers by Ece Bayram Breakdown of academic impact, for papers by Abbas Dehghani Firouzabadi
Rankless by CCL
2026